Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT07014449 · RECRUITING

Trial details

NCT number: NCT07014449
Sponsor: Hangzhou Weben Pharma Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

AML (Acute Myelogenous Leukemia Relapsed Acute Myelogenous Leukemia Refractory Acute Myeloid Leukemia Hematologic Malignancy C-Myc Adult Acute Myeloid Leukemia

Start date: 2024-11-03
Primary completion: 2026-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.